Stay updated on Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial

Sign up to get notified when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site revision label changed from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-18T01:38:20.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays the clinical trial record, including its study details, outcome measures, publications, and supporting documents, instead of a 403 error.
    Difference
    100%
    Check dated 2026-11-10T22:45:48.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0. The study record remains inaccessible and displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T22:58:11.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    A general NIH website-transition notice appears above the ClinicalTrials.gov page, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:09:30.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-06T22:03:51.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, indicating access is blocked. This reflects a permission or access issue rather than a change in the underlying study data.
    Difference
    0.5%
    Check dated 2026-09-29T22:26:06.000Z thumbnail image

Stay in the know with updates to Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.